| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $25.02 ▲ +2.03% | Yesterday | $24.31 ▼ -0.85% | Tomorrow's Arcus Biosciences Inc. Common Stock (RCUS) setup is anchored to $24.52 and targets $25.02 (+2.03%). The near-term read is upside; watch $25.26 / $23.78 because daily realized volatility is about 8.00%. |
Tomorrow's Arcus Biosciences Inc. Common Stock (RCUS) setup is anchored to $24.52 and targets $25.02 (+2.03%). The near-term read is upside; watch $25.26 / $23.78 because daily realized volatility is about 8.00%. | ||||
| Week | $26.07 ▲ +6.31% | Last Week | $23.87 ▼ -2.65% | The 7-day Arcus Biosciences Inc. Common Stock model moves from $23.87 to $26.07 (+6.31%). It gives upside momentum context for this stock, so breaks around $25.26 / $23.78 matter more than a single tick. |
The 7-day Arcus Biosciences Inc. Common Stock model moves from $23.87 to $26.07 (+6.31%). It gives upside momentum context for this stock, so breaks around $25.26 / $23.78 matter more than a single tick. | ||||
| Month | $27.82 ▲ +13.45% | Last Month | $23.14 ▼ -5.65% | The 1-month Arcus Biosciences Inc. Common Stock target is $27.82 (+13.45%), compared with the live reference near $24.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Arcus Biosciences Inc. Common Stock target is $27.82 (+13.45%), compared with the live reference near $24.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $30.44 ▲ +24.14% | Last Year | $22.03 ▼ -10.14% | The 1-year Arcus Biosciences Inc. Common Stock scenario points to $30.44 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Arcus Biosciences Inc. Common Stock scenario points to $30.44 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $36.58 ▲ +49.20% | 5 Years Ago | $19.45 ▼ -20.66% | The 5-year Arcus Biosciences Inc. Common Stock view is $36.58 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Arcus Biosciences Inc. Common Stock view is $36.58 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $24.52 | Mid |
| Daily Change | +7.83% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 74% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $24.52 | Daily Change | +7.83% |
| Market Cap | $3.07B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.